Tinkerine Studios Ltd. (TSXV:TTD), a Canadian 3D printing stock, jumped after receiving approval from Health Canada for COVID-19 Medical Device Authorization
Health Canada approval for a COVID-19 medical device lifted a Canadian 3D printing stock Tuesday. Here’s some small stocks making big moves on Tuesday, April 28, 2020 (as of 4 pm EST):
Tinkerine Studios Ltd. (TSXV:TTD), a Canadian 3D printing stock, powered 37% higher to $0.185 on Tuesday after announcing the receipt of approval from Health Canada for COVID-19 Medical Device Authorization for Importation or Sale of Class 1 Medical Devices.
As well, shares of Probe Metals Inc. (TSXV:PRB) rose 5% to $1.05 as the gold explorer released results from the winter drill program on its 100% owned Val-d’Or East Monique property in Quebec, which included 5.2 grams per tonne (g/t) gold over 14.0 metres.
Datable Technology Corporation (TSXV:DAC), meanwhile, reported that it has signed an agreement with an advertising agency to provide a license for PLATFORM and digital rewards to a global provider of household and industrial products, in which Datable will be paid approximately C$1.087 million in 2020. Datable Technology stock moved up 25% to $0.05 following the announcement.
Finally, First Mexican Gold Corp. (TSXV:FMG) shares gained 27% to $0.19 after the junior explorer announced the acquisition of a 100% interest in the Golden Giant project located in the James Bay lowlands area of Quebec, which is immediately contiguous with Azimut Exploration Inc.’s Patwon gold discovery.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.